MUTAMYCIN
MUTAMYCIN is not recommended as single-agent, primary therapy. It has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliativ

Also known as: mitomycin

Manufacturer: Bristol-Myers Squibb Company

Brand Name: *

Avg Rating: Read reviews about MUTAMYCIN - write a review